Latest news, Wikipedia summary, and trend analysis.
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
4C-TFM entered the ranking for the first time today at position #. This is its highest position ever recorded.
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-08-19 and was most recently seen on 2026-08-19.
4C-TFM, also known as TFM-Ariadne or 4C-DOTFM, as well as 4-trifluoromethyl-2,5-dimethoxy-α-ethylphenethylamine, is a serotonin 5-HT2 receptor agonist of the phenethylamine, phenylisobutylamine, and 4C families related to Ariadne (4C-D). It is a close analogue of the psychedelic drugs 2C-TFM and DOTFM, with 2C-TFM having no substitution at the α carbon, DOTFM having an α-methyl group, and 4C-TFM having an α-ethyl group. The drug is a potent agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors. It shows similar efficacy as an agonist of these receptors as Ariadne, but shows about 6.4-fold higher potency as a serotonin 5-HT2A receptor agonist in comparison. Like Ariadne, 4C-TFM produces an attenuated head-twitch response relative to the psychedelic drug DOPR, with a similar maximal response as Ariadne. The chemical synthesis of 4C-TFM has been described. 4C-TFM was first described in the scientific literature by Michael Cunningham and colleagues in 2023.
Read more on Wikipedia →No recent news articles found.
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.